FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA
May 1, 2024, 04:54 |
Blog
Howard McLeod: Preemptive DPYD Testing Program for patients planned for a systemic Fluoropyrimidine
Howard McLeod, Central Director, Founder and Advisor at Precision Medicine, shared on LinkedIn: “The USA…
Apr 29, 2024, 07:58 |
Blog
Rahul Gosain: FDA approval of Fruquintinib from FRESCO2 and how it fits in our Rx paradigm with N. Arvind Dasari
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 28, 2024, 14:39 |
Blog
Harpreet Singh: Join us for what promises to be an exciting and informative workshop on the approach to resectable, early stage tumors
Harpreet Singh, Division Direction at FDA Oncology shared a post by American Association for Cancer…
Apr 27, 2024, 10:46 |
Blog
Drew Moghanaki: Our residents at UCLA experienced a truly engaging lecture about SCLC by Jie Deng
Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared on X/Twitter: "Our residents…
Apr 26, 2024, 20:41 |
Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
Apr 26, 2024, 11:03 |
Blog
Vivek Subbiah: FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
Vivek Subbiah shared a post on X: "FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive…
Apr 25, 2024, 15:40 |
Blog
BioTrinity 2024 in the City of London - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "Calling companies and potential partners…
Apr 24, 2024, 09:13 |
Drugs
FDA approves nogapendekin alfa inbakicept-pmln for BCG-unresponsive non-muscle invasive bladder cancer
FDA, the Food and Drug Administration, approved nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience, LLC) with…
Apr 23, 2024, 23:38 |
Drugs
Vincent Rajkumar: All the drug approvals for relapsed multiple myeloma in 20 years
Tina Crosbie, Hematology Pharmacist at The Ottawa Hospital and at Extend Pharmacy, shared a post…
Apr 21, 2024, 23:34 |
Blog
Svetlana Nikic: Comprehensive and structured list of FDA-approved CDx NGS assays. Super easy to be found at FDA's website
Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn: "With an overwhelming amount…
1
2
3
4
5
All:
138
Posts:
21 - 30
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube